State Street’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,236,946
| Closed | -$1.44M | – | 5014 |
|
|
2022
Q2 | $1.44M | Sell |
1,236,946
-193,853
| -14% | -$203K | ﹤0.01% | 3560 |
|
|
2022
Q1 | $1.54M | Buy |
1,430,799
+130,894
| +10% | +$98.9K | ﹤0.01% | 3660 |
|
|
2021
Q4 | $936K | Sell |
1,299,905
-16,009
| -1% | -$12.9K | ﹤0.01% | 3830 |
|
|
2021
Q3 | $1.19M | Buy |
1,315,914
+93,523
| +8% | +$113K | ﹤0.01% | 3747 |
|
|
2021
Q2 | $2.03M | Buy |
1,222,391
+220,512
| +22% | +$369K | ﹤0.01% | 3545 |
|
|
2021
Q1 | $2.09M | Buy |
1,001,879
+24,008
| +2% | +$49.9K | ﹤0.01% | 3423 |
|
|
2020
Q4 | $1.22M | Buy |
977,871
+308,823
| +46% | +$368K | ﹤0.01% | 3522 |
|
|
2020
Q3 | $816K | Buy |
669,048
+44,184
| +7% | +$53.7K | ﹤0.01% | 3493 |
|
|
2020
Q2 | $731K | Sell |
624,864
-199,687
| -24% | -$185K | ﹤0.01% | 3483 |
|
|
2020
Q1 | $674K | Buy |
824,551
+15,725
| +2% | +$16.7K | ﹤0.01% | 3390 |
|
|
2019
Q4 | $817K | Buy |
808,826
+40,939
| +5% | +$49.6K | ﹤0.01% | 3443 |
|
|
2019
Q3 | $1.08M | Sell |
767,887
-11,733
| -2% | -$16.6K | ﹤0.01% | 3378 |
|
|
2019
Q2 | $1.17M | Sell |
779,620
-35,292
| -4% | -$54.6K | ﹤0.01% | 3395 |
|
|
2019
Q1 | $1.25M | Sell |
814,912
-97,022
| -11% | -$148K | ﹤0.01% | 3295 |
|
|
2018
Q4 | $1.34M | Buy |
911,934
+32,900
| +4% | +$50.4K | ﹤0.01% | 3257 |
|
|
2018
Q3 | $1.61M | Buy |
879,034
+71,163
| +9% | +$138K | ﹤0.01% | 3322 |
|
|
2018
Q2 | $1.49M | Buy |
807,871
+797,071
| +7,380% | +$1.48M | ﹤0.01% | 3350 |
|
|
2018
Q1 | $22K | Hold |
10,800
| – | – | ﹤0.01% | 3712 |
|
|
2017
Q4 | $12K | Hold |
10,800
| – | – | ﹤0.01% | 3709 |
|
|
2017
Q3 | $12K | Hold |
10,800
| – | – | ﹤0.01% | 3739 |
|
|
2017
Q2 | $14K | Hold |
10,800
| – | – | ﹤0.01% | 3673 |
|
|
2017
Q1 | $21K | Hold |
10,800
| – | – | ﹤0.01% | 3617 |
|
|
2016
Q4 | $23K | Hold |
10,800
| – | – | ﹤0.01% | 3607 |
|
|
2016
Q3 | $19K | Hold |
10,800
| – | – | ﹤0.01% | 3537 |
|
|
2016
Q2 | $9K | Hold |
10,800
| – | – | ﹤0.01% | 3705 |
|
|
2016
Q1 | $10K | Hold |
10,800
| – | – | ﹤0.01% | 3704 |
|
|
2015
Q4 | $12K | Hold |
10,800
| – | – | ﹤0.01% | 3685 |
|
|
2015
Q3 | $23K | Sell |
10,800
-17,700
| -62% | -$34.5K | ﹤0.01% | 3648 |
|
|
2015
Q2 | $56K | Sell |
28,500
-89,889
| -76% | -$255K | ﹤0.01% | 3578 |
|
|
2015
Q1 | $459K | Buy |
118,389
+4,412
| +4% | +$16.3K | ﹤0.01% | 3381 |
|
|
2014
Q4 | $411K | Buy |
113,977
+29,834
| +35% | +$79K | ﹤0.01% | 3424 |
|
|
2014
Q3 | $224K | Buy |
84,143
+20,892
| +33% | +$140K | ﹤0.01% | 3468 |
|
|
2014
Q2 | $735K | Buy |
63,251
+9,909
| +19% | +$112K | ﹤0.01% | 3289 |
|
|
2014
Q1 | $744K | Buy |
53,342
+8,218
| +18% | +$129K | ﹤0.01% | 3310 |
|
|
2013
Q4 | $804K | Buy |
45,124
+10,124
| +29% | +$164K | ﹤0.01% | 3283 |
|
|
2013
Q3 | $589K | Buy |
+35,000
| New | +$491K | ﹤0.01% | 3327 |
|
State Street's MBII Position: Q3 2022 in Review
State Street sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 1,236,946 shares — an estimated $1.44M sold.
State Street first reported a position in MBII in Q3 2013 and held it in 36 quarters. The position peaked at $2.09M in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- State Street reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- State Street sold 1,236,946 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1.44M.
- State Street first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 36 quarters.
- State Street's Marrone Bio Innovations, Inc. position peaked at $2.09M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.